Memorial Sloan Kettering Cancer Center: Single Audit Reports and Findings

Memorial Sloan Kettering Cancer Center's most recent single audit in the Federal Audit Clearinghouse covers fiscal year 2023, accepted September 30, 2024; the auditor observed on that filing is Ernst & Young LLP. It reported 1 finding. 8 filings from 2016 to 2023 are on record. Data as of 2026-11-06.

Data as of Nov 6, 2026 · Source: Federal Audit Clearinghouse (public data)

Single audits by year

One row per audit year as the Federal Audit Clearinghouse accepted it. The auditor named is the one observed on that filing; Memorial Sloan Kettering Cancer Center is recorded in NEW YORK, New York under EIN 131624182, and the Clearinghouse records it as a nonprofit. Each report opens on the Clearinghouse itself; how to search the Federal Audit Clearinghouse explains the rest of the reporting package.

Single audits filed by Memorial Sloan Kettering Cancer Center
Audit yearFiscal year endFederal expendedThreshold appliedAuditor observedOpinionFindingsMW / SDFAC report
20232023-12-31$339,704,011$750,000Ernst & Young LLPUnmodified1SD2023-12-GSAFAC-0000052652
20222022-12-31$470,386,531$750,000Ernst & Young LLPUnmodified0—2022-12-CENSUS-0000199567
20212021-12-31$349,065,491$750,000Ernst & Young LLPUnmodified0—2021-12-CENSUS-0000199567
20202020-12-31$194,115,182$750,000Ernst & Young LLPUnmodified0—2020-12-CENSUS-0000199567
20192019-12-31$201,811,331$750,000Ernst & Young LLPUnmodified0—2019-12-CENSUS-0000199567
20182018-12-31$188,005,806$750,000Ernst & Young LLPUnmodified0—2018-12-CENSUS-0000199567
20172017-12-31$174,119,930$750,000Ernst & Young LLPUnmodified0—2017-12-CENSUS-0000199567
20162016-12-31$149,600,820$750,000Ernst & Young LLPUnmodified0—2016-12-CENSUS-0000199567

When is the next single audit due?

If Memorial Sloan Kettering Cancer Center is again required to have a single audit for the fiscal year ending Dec 31, 2024, the reporting package is due to the Federal Audit Clearinghouse by Sep 30, 2025 at the latest.

No filing for that fiscal year appears in the Clearinghouse data as of Nov 6, 2026. The data does not show why: an organization below the threshold is not required to file, and a filing can be accepted after the due date.

Whether an audit is required depends on federal awards expended in that year (the single audit threshold). The rule, 2 CFR 200.512(a): the reporting package is due within 30 calendar days after the auditee receives the auditor's report or nine months after the end of the audit period, whichever is earlier; the date above is the nine-month date, moved to Monday when it falls on a weekend. Last verified: 2026-11-15.

Which federal programs did this organization report?

From the most recent accepted report, as listed on its schedule of expenditures of federal awards (SEFA). "Major" is the designation the auditor made under 2 CFR 200.518, not ours.

Federal programs on the most recent report
ALNProgramExpendedMajor
93.498PROVIDER RELIEF FUND$73,135,307Yes
93.855ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH$30,778,358Yes
93.395CANCER TREATMENT RESEARCH$29,833,637Yes
93.396CANCER BIOLOGY RESEARCH$29,611,924Yes
93.397CANCER CENTERS SUPPORT GRANTS$28,619,021Yes
93.394CANCER DETECTION AND DIAGNOSIS RESEARCH$19,657,975Yes
93.393CANCER CAUSE AND PREVENTION RESEARCH$19,610,997Yes
93.859BIOMEDICAL RESEARCH AND RESEARCH TRAINING$18,052,084Yes
12.420MILITARY MEDICAL RESEARCH AND DEVELOPMENT$12,757,983Yes
93.398CANCER RESEARCH MANPOWER$10,417,752Yes
93.172HUMAN GENOME RESEARCH$7,361,054Yes
93.866AGING RESEARCH$6,207,950Yes
93.853EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$5,349,091Yes
93.35321ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT$4,026,143Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$2,844,744Yes
93.286DISCOVERY AND APPLIED RESEARCH FOR TECHNOLOGICAL INNOVATIONS TO IMPROVE HUMAN HEALTH$2,387,655Yes
93.839BLOOD DISEASES AND RESOURCES RESEARCH$2,215,178Yes
93.865CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH$1,859,637Yes
93.310TRANS-NIH RESEARCH SUPPORT$1,525,378Yes
93.307MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH$1,342,890Yes
93.855ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH$1,274,508Yes
93.846ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH$921,456Yes
93.396CANCER BIOLOGY RESEARCH$881,749Yes
93.35321ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT$861,005Yes
93.361NURSING RESEARCH$824,123Yes

What findings did the auditor report?

The reference is the auditor’s; the requirement is the Compliance Supplement category the auditor selected. The finding text itself is not reproduced here; the FAC report linked above carries it in full. What the two severity levels mean: material weakness vs significant deficiency.

Findings on the most recent report
ReferenceRequirementSeverityRepeat
2023-001Procurement and suspension and debarment (I)Significant deficiency / Questioned costsNo

Form 990 and IRS registration

Form 990 "accounting fees" (Part IX line 11c) cover all accounting services reported by the organization and are not the price of an audit engagement.

Where to find the return itself, and what our Form 990 data covers: Form 990 lookup.

NTEE code
H30Z
Exempt under
501(c)(3)
Ruling year
1962
BMF release
2026-10-20

Read next

How we computed this

Every row comes from the Federal Audit Clearinghouse record named beside it, one report per audit year, with a resubmission superseding the filing it replaces. The auditor is the one named on that filing — it is not a statement about who audits Memorial Sloan Kettering Cancer Center now. Form 990 figures come from the IRS e-filed return named by its object id. This page exists because the organization filed at least two single audits, or one with a finding.

Cite this page

AuditRadar. “Memorial Sloan Kettering Cancer Center Single Audit FY2023 (NY).” https://getauditradar.com/single-audits/ny/memorial-sloan-kettering-cancer-center-131624182/. Data as of 2026-11-06.